About Lantern Pharma
Lantern Pharma is a company based in Dallas (United States) founded in 2013. It operates as a AI-as-a-Service, and Professional Services. Lantern Pharma has raised $7.12 million across 5 funding rounds from investors including United States Department of Agriculture, Bios Partners and Green Park & Golf Ventures. The company has 24 employees as of December 31, 2024. Lantern Pharma offers products and services including LP-300 and RADR Platform. Lantern Pharma operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Natera, among others.
- Headquarter Dallas, United States
- Employees 24 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lantern Pharma Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-20.78 M-30.2as on Dec 31, 2024
-
EBITDA
$-22.03 M-24.42as on Dec 31, 2024
-
Total Equity Funding
$7.12 M (USD)
in 5 rounds
-
Latest Funding Round
$20 K (USD), Grant
Jan 03, 2022
- Investors
-
Employee Count
24
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lantern Pharma
Lantern Pharma is a publicly listed company on the NASDAQ with ticker symbol LTRN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Lantern Pharma
Lantern Pharma offers a comprehensive portfolio of products and services, including LP-300 and RADR Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational drug for non-small cell lung cancer treatment.
AI platform for oncology drug development and testing.
Unlock access to complete
Unlock access to complete
Funding Insights of Lantern Pharma
Lantern Pharma has successfully raised a total of $7.12M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $20 thousand completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $20,000
-
First Round
First Round
(28 Aug 2014)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Grant - Lantern Pharma | Valuation |
investors |
|
| Mar, 2019 | Amount | Series A - Lantern Pharma | Valuation |
investors |
|
| May, 2017 | Amount | Series A - Lantern Pharma | Valuation | Bios Partners , Green Park & Golf Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lantern Pharma
Lantern Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include United States Department of Agriculture, Bios Partners and Green Park & Golf Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided by Bios Partners for biotech innovation.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are made in medical startups.
|
Founded Year | Domain | Location | |
|
Healthcare startups are accelerated via a 12-week funding program.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lantern Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lantern Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lantern Pharma Comparisons
Competitors of Lantern Pharma
Lantern Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Natera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lantern Pharma
Frequently Asked Questions about Lantern Pharma
When was Lantern Pharma founded?
Lantern Pharma was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Lantern Pharma located?
Lantern Pharma is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Is Lantern Pharma a funded company?
Lantern Pharma is a funded company, having raised a total of $7.12M across 5 funding rounds to date. The company's 1st funding round was a Series A of $3.7M, raised on Aug 28, 2014.
How many employees does Lantern Pharma have?
As of Dec 31, 2024, the latest employee count at Lantern Pharma is 24.
What does Lantern Pharma do?
Lantern Pharma is engaged in transforming oncology drug discovery and development through the use of artificial intelligence, machine learning, and genomics. The company is dedicated to delivering precision therapies for cancer patients across multiple indications. Their portfolio includes three lead drug candidates and an ADC program targeting 12 cancer types. Clinical trials, such as the Harmonic Phase 2 study, are conducted to evaluate investigational drugs. Costs and timelines are aimed to be significantly reduced through their proprietary RADR platform, one of the largest AI-powered platforms for oncology therapeutics.
Who are the top competitors of Lantern Pharma?
Lantern Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Lantern Pharma offer?
Lantern Pharma offers LP-300 and RADR Platform.
Is Lantern Pharma publicly traded?
Yes, Lantern Pharma is publicly traded on NASDAQ under the ticker symbol LTRN.
Who are Lantern Pharma's investors?
Lantern Pharma has 4 investors. Key investors include United States Department of Agriculture, Bios Partners, Green Park & Golf Ventures, and Health Wildcatters.
What is Lantern Pharma's ticker symbol?
The ticker symbol of Lantern Pharma is LTRN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.